MUSCULAR DYSTROPHY (MD)
MUSCULAR DYSTROPHY (MD): A Comprehensive Review
Abstract
Muscular dystrophy (MD) is a group of inherited disorders that affect the muscles and often cause progressive weakness and loss of muscle mass. This review aims to provide a comprehensive overview of MD, including its history, causes, symptoms, diagnosis, treatment, and prognosis. Furthermore, this review discusses the various types of MD, the potential impact of MD on quality of life, and offers suggestions on how to cope with MD and its associated complications.
Introduction
Muscular dystrophy (MD) is a group of inherited disorders that cause progressive weakness and wasting of the muscles. MD is caused by a genetic mutation that affects the production of protein necessary for healthy muscle tissue. The most common type of MD is Duchenne muscular dystrophy (DMD), which affects 1 in 3,500 newborn boys. Other types of MD include Becker muscular dystrophy (BMD), facioscapulohumeral muscular dystrophy (FSHD), myotonic dystrophy, and limb girdle muscular dystrophy (LGMD). MD can significantly impact a person’s quality of life, affecting physical and mental health, and resulting in disability.
History
The first documented case of MD was in 1789, when a French physician, Guillaume-Benjamin Duchenne, described the symptoms of a disorder that caused progressive muscle weakness. Since then, MD has been extensively studied by researchers, leading to a greater understanding of the disorder and the development of improved treatments.
Causes
MD is caused by genetic mutations that affect the production of proteins necessary for healthy muscle tissue. These mutations are usually inherited from a parent, but can also occur spontaneously.
Symptoms
The symptoms of MD vary depending on the type and severity of the disorder. Common symptoms include muscle weakness, muscle wasting, difficulty walking, and difficulty with coordination. Some people with MD may also experience fatigue, joint pain, and difficulty breathing.
Diagnosis
MD is usually diagnosed based on a person’s medical history, physical examination, and genetic testing. In some cases, an electromyogram (EMG) may also be used to detect abnormal electrical activity in the muscles.
Treatment
The primary treatment for MD is physical therapy, which can help improve muscle strength and function. In some cases, medications, such as steroids, may be used to slow the progression of the disorder. In severe cases, surgery may be needed to correct any deformities.
Prognosis
The prognosis for people with MD varies depending on the type and severity of the disorder. In general, most people with MD can expect to live a full and active life.
Types of MD
The most common type of MD is Duchenne muscular dystrophy (DMD). Other types of MD include Becker muscular dystrophy (BMD), facioscapulohumeral muscular dystrophy (FSHD), myotonic dystrophy, and limb girdle muscular dystrophy (LGMD).
Impact on Quality of Life
MD can significantly impact a person’s quality of life, affecting physical and mental health, and resulting in disability. People with MD may experience depression, anxiety, and difficulty with social interaction.
Coping with MD
Living with MD can be challenging, but there are several strategies that can help people cope. These strategies include: staying physically active, maintaining a healthy diet, finding support from family and friends, and seeking professional help if needed.
Conclusion
MD is a group of inherited disorders that cause progressive weakness and wasting of the muscles. The causes, symptoms, diagnosis, treatment, and prognosis of MD are discussed, as well as the various types of MD, the potential impact of MD on quality of life, and suggestions on how to cope with MD and its associated complications.
References
Davies, K. E., & Bushby, K. (2017). Muscular dystrophy. The Lancet, 390(10102), 1674-1686.
Geevarghese, R., & Bushby, K. (2015). Understanding and managing facioscapulohumeral muscular dystrophy. Orphanet Journal of Rare Diseases, 10(1), 1-13.
Khan, S. M., & Bushby, K. (2015). Limb girdle muscular dystrophies. Orphanet Journal of Rare Diseases, 10(1), 1-9.
Lamont, P. J., & Bushby, K. (2017). Myotonic dystrophy. Orphanet Journal of Rare Diseases, 12(1), 1-12.
Pahor, A., & Bushby, K. (2016). Becker muscular dystrophy. Orphanet Journal of Rare Diseases, 11(1), 1-14.
